Gennex Laboratories board approved the schedule for its 41st Annual General Meeting and key audit reports on September 4, 2026. The company will hold the meeting via video conferencing on September 30.

The board considered several compliance items during the session, which commenced at 4:00 pm and concluded at 5:00 pm. Key approvals included the draft directors' report for the financial year ending March 31, 2026. The company also finalized logistics for shareholder participation, including e-voting arrangements.

Meeting Logistics

The 41st AGM is scheduled for Wednesday, September 30, 2026, at 12:30 pm. The event will be conducted through video conferencing or other audio-visual means (VC/OAVM). Ms. Sweety Kapoor, a practicing company secretary based in Kolkata, has been appointed as the scrutinizer for the meeting.

National Securities Depository Limited (NSDL) serves as the authorized agency to facilitate the AGM and provide e-voting facilities. The e-voting period runs from Sunday, September 27, 2026, at 9:00 am to Tuesday, September 29, 2026, at 5:00 pm. The cut-off date for voting eligibility is September 23, 2026.

The book closure period coincides with the meeting date, running from September 23, 2026, to September 30, 2026. Shareholders holding equity shares within this window are eligible to vote.

Audit Approvals

The board approved two critical audit reports for the fiscal year ended March 31, 2026:

• Secretarial Audit Report issued by Mr. Md. Tausif Shamim, practicing company secretary in Kolkata.
• Cost Audit Report issued by M/s. Sai Krishna & Associates, cost accountants.

These approvals ensure regulatory compliance under Regulation 30 of the SEBI (LODR) Regulations, 2015. The company submitted these details to stock exchanges including BSE Limited, Ahmedabad Stock Exchange Limited, and Calcutta Stock Exchange Limited.

What the Numbers Show

This filing contains no financial performance data. It serves purely as a procedural notice regarding corporate governance timelines. Investors should monitor subsequent filings for FY26 financial results, which were not disclosed in this communication.

Gennex Laboratories has scheduled a Board of Directors meeting for Friday, September 4, 2026. The session will be held at its corporate office in Hyderabad.

The primary agenda item involves deciding regarding the conduct of the company's 41st Annual General Meeting for the year ended March 31, 2026.

Meeting Agenda

The board will also consider the appointment of a scrutinizer for the AGM, contingent upon the finalization of the meeting date. Any other business may be discussed with the permission of the Chairperson.

This intimation is issued pursuant to Regulation 29 of the SEBI (LODR) Regulations, 2015. The company has uploaded the notice on its official website.